The Competition Commission of India (CCI) has cleared Manipal group chief Ranjan Pai's investment in online pharmacy PharmEasy

Unlisted Deals:

ador powertron 500.00 (4,900.00 %) aitmc formerly avpl 63.00 (1.61 %) amol minechem 910.00 (1.11 %) anglo french drugs 1,000.00 (5.26 %) anugraha valve 540.00 (2.86 %) apl metals 39.00 (-2.50 %) apollo fashion 90.00 (-2.17 %) arohan 250.00 (-1.96 %) assam carbon 360.00 (2.86 %) avalokiteshvar 242.00 (0.83 %) axles india 650.00 (-0.76 %) balmer lawrie 200.00 (-0.99 %) bharat hotels 380.00 (-1.30 %) bima mandi 235.00 (-2.08 %) bira 525.00 (-1.87 %) bliss enterprise 35.00 (2.94 %) boat 1,710.00 (0.59 %) c & s electric 1,070.00 (1.90 %) cable corporation 11.10 (0.91 %) capgemini 14,100.00 (-0.70 %) care health 184.00 (2.22 %) carrier aircon 575.00 (0.88 %) cial 465.00 (2.20 %) csk 191.00 (-0.52 %) dalmia refract 270.00 (-1.82 %) dfm foods 470.00 (0.64 %) dsp merrill lynch 1,000.00 east india pharma 39.00 (-2.50 %) eaton fluid 445.00 (1.14 %) electronica plastic 4,500.00 (2.27 %) elgi ultra 400.00 elofic industries 2,850.00 (1.79 %) esl steel 42.00 (-2.33 %) fincare business 87.00 (1.16 %) fincare sfbl 205.00 (1.49 %) finopaytech limited 135.00 (-3.57 %) frick india 3,350.00 (-1.47 %) gkn driveline 1,800.00 (-0.99 %) goodluck defence 288.00 (-0.69 %) group pharma 300.00 gynofem healthcare 75.00 (2.74 %) hazira cargo terminals limited 205.00 (1.49 %) hdb financial 1,190.00 (-0.83 %) hdfc ergo 370.00 (1.70 %) hdfc securities 10,500.00 (-0.94 %) hella india 900.00 (-2.17 %) hero fincorp 1,950.00 (-0.76 %) hexaware 1,025.00 (-1.44 %) hicks 1,650.00 (3.13 %) hinduja leyland 260.00 hira ferro 200.00 (2.56 %) honeywell electrical 7,600.00 (1.33 %) ikf finance 320.00 (3.23 %) incred holdings 155.00 (1.31 %) incred prime 10.00 (1.01 %) india carbon 1,100.00 (-1.79 %) india exposition 121.00 (0.83 %) indian potash 3,150.00 (1.61 %) indian seamless 195.00 (2.63 %) indo alusys 25.75 (-0.96 %) indofil 1,380.00 (-0.36 %) infinite computer 405.00 (1.25 %) inkel 22.00 (-2.22 %) jana small finance bank 75.00 kel 475.00 (-5.00 %) kial 133.00 (-2.92 %) klm axiva 16.00 (3.23 %) kurlon limited 1,275.00 (1.59 %) lava 42.00 (-1.18 %) mahindra rural mrhfl 100.00 manipal housing 74.00 (2.07 %) manjushree technopack 825.00 (-2.94 %) martin & harris 820.00 (-1.20 %) matrix gas 795.00 (-0.63 %) merino 3,300.00 (1.54 %) minosha 282.00 (0.71 %) mitsubishi heavy 207.00 (-0.48 %) mkcl 425.00 (-2.30 %) mohan meakin 2,300.00 (-4.17 %) mohfl 19.50 (-2.50 %) msei 11.75 (2.17 %) msil 31.00 (3.33 %) nayara energy 1,650.00 (3.13 %) nayara energy ncd 330.00 (3.13 %) ncdex 202.00 (-1.46 %) ncl buildtek 305.00 (-4.69 %) ncl holdings 106.00 (0.95 %) nsdl 1,000.00 (-0.99 %) nse india 1,800.00 (-2.70 %) onix renewable 24,000.00 (4.35 %) orbis financial 460.00 (2.22 %) oswal minerals 60.10 (-1.48 %) otis elevator 4,100.00 (2.50 %) oyo rooms 56.00 (5.66 %) panasonic appliances 270.00 (3.05 %) paymate india 500.00 (-1.96 %) pharmeasy 8.50 (-1.16 %) pharmed limited 675.00 (2.27 %) philips domestic 575.00 (-4.17 %) philips india 925.00 (-0.54 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 260.00 (-1.89 %) rapido 16,650.00 (0.03 %) rasoi 82,000.00 (2.50 %) reliance gic 565.00 (1.80 %) resins plastics 575.00 (2.68 %) ring plus aqua 580.00 (3.57 %) rrp s4e innovation 299.00 (-6.56 %) sab miller 535.00 (0.94 %) sbi amc 2,650.00 (0.95 %) sbi general insurance 621.00 (0.16 %) scottish assam 505.00 (1.00 %) shriram life 261.00 (0.38 %) sigachi laboratories 36.00 (-2.70 %) signify 1,325.00 (-1.85 %) smile microfinance 51.00 (-1.92 %) sterlite grid 5 300.00 (3.45 %) sterlite power 660.00 (-0.75 %) studds 1,400.00 (0.72 %) svsml 315.00 (2.94 %) t stanes 800.00 (1.27 %) tata capital 1,000.00 (-0.99 %) trl krosaki 1,800.00 (2.86 %) urban tots 64.00 (-1.54 %) utkarsh coreinvest 285.00 (-1.72 %) vikram solar 460.00 (-3.16 %) vivriti capital 1,040.00 (-0.95 %)

CCI Approves Ranjan Pai Investment in Pharmeasy

API Holdings Ltd

Created at 26 Mar 2024 08:08

The Competition Commission of India (CCI) has cleared Manipal group chief Ranjan Pai's investment in online pharmacy PharmEasy, according to the latest filing by the antitrust regulator. An additional investment from 360 One (formerly IIFL) in PharmEasy has also been cleared.

Pai's investment in PharmEasy is part of the Rs 3,500-crore funding through a rights issue. He has emerged as one of the largest investors in the Mumbai-based firm, with his stake now estimated at more than 12%. PharmEasy’s rights issue was initially planned for Rs 2,400 crore, but later bumped up to Rs 3,500 crore. It was priced at a 90% discount to PharmEasy’s peak valuation of $5.6 billion in 2021. The company had to undertake the rights issue to clear the debt it had taken from Goldman Sachs. Pai, over the past year, has increased his pace of investment through his family office, with significant investments in companies like Byjus-owned Aakash Institute, omnichannel jewelry maker Bluestone, and baby and mother care e-commerce firm FirstCry along with others.

PharmEasy has been reducing its monthly burn and growing sustainably. Pai is expected to give a strategic direction to the firm following his investment. It has lost market share to rivals like Tata Digital-owned 1mg. Flipkart Health Plus, Apollo, and Reliance-owned Netmeds are the other players in the sector.

https://economictimes.indiatimes.com

News Alert